	DETTE		Date
AbbVie	USD 1000K	70.48B	2025-09
Acadia Pharmaceuticals	USD 56.29M	1.36M	2025-06
ALKERMES	USD 71.6M	1.08M	2025-09
Amgen	USD 54.59B	1.62B	2025-09
Biogen	USD 6.29B	1.7M	2025-12
BioMarin Pharmaceutical	USD 604.24M	375K	2025-09
Bristol-Myers Squibb	USD 51.04B	112M	2025-09
Coherus Biosciences	USD 294.92M	1.25M	2025-03
Eli Lilly	USD 42.51B	2.6B	2025-09
Gilead Sciences	USD 24.94B	5M	2025-09
Heron Therapeutics	USD 149.65M	157K	2024-09
Ionis Pharmaceuticals	USD 1.23B	192.99M	2025-09
J&J	USD 45.8B	4.97B	2025-09
Malin Corporation	EUR 100K	0	2023-12
Merck	USD 41.37B	5.97B	2025-09
Minerva Neurosciences	USD 0	0	2024-09
Nektar Therapeutics	USD 0	0	2022-06
Neurocrine Biosciences	USD 428.4M	10.7M	2025-09
Otsuka Holdings	JPY 211.51B	41.2B	2025-06
Ovoca Bio	EUR 0	0	2021-06
Pfizer	USD 60.85B	78M	2025-09
Regeneron Pharmaceuticals	USD 2.71B	400K	2025-09
Vertex Pharmaceuticals	USD 1.83B	307.4M	2025-09

ALKERMES DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.